Nancy Thomason

Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC.

HAP Investments LLC acquires and develops mid sized residential and commercial properties. The firm specializes in global real estate markets, property development, real estate finance and law. The company was founded by Eran Polack, Amir Hasid, and Nir Amsel in 2010 and is headquartered in New York, NY.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA.

Parata Systems LLC engages in the provision of pharmacy technology solutions. It offers pharmacy automation, medication management, pharmacy workflow integration, medication packaging, and long term care medication solutions. The company was founded by Jess Eberdt and W. L. Townsend in 2001 and is headquartered in Durham, NC.